| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/23/2009 | US20090186065 Isolating and purifying cells for therapy |
| 07/23/2009 | US20090186048 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 07/23/2009 | US20090186043 Method and compositions for preventing and treating streptococcus pneumoniae infection |
| 07/23/2009 | US20090186037 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 07/23/2009 | US20090186035 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 07/23/2009 | US20090186034 Gene expression markers for inflammatory bowel disease |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186029 Anticholesterol agents; generating an antibody which binds specifically to a C-terminal fragment of a vertebrate hedgehog polypeptide, comprising immunizing a mammalian subject with the C-terminal fragment |
| 07/23/2009 | US20090186021 Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents |
| 07/23/2009 | US20090186018 Compositions and methods for the treatment of rheumatoid arthritis |
| 07/23/2009 | US20090186013 Inorganic materials for hemostatic modulation and therapeutic wound healing |
| 07/23/2009 | US20090186012 Plant extract |
| 07/23/2009 | US20090186011 Manufacture of Active Highly Phosphorylated Human Lysosomal Sulfatase Enzymes and Uses Thereof |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090186008 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2009 | US20090186003 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 07/23/2009 | US20090186002 rAAV-delivered alpha-1-antitrypsin compositions and method for the treatment and prevention of diabetes |
| 07/23/2009 | US20090186000 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma |
| 07/23/2009 | US20090185999 Derivatives of gefitinib |
| 07/23/2009 | US20090185998 New activated poly(ethylene glycols) and related polymers and their applications |
| 07/23/2009 | US20090185997 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/23/2009 | US20090185996 Hydroxyethyl starch-containing polypeptide compositions |
| 07/23/2009 | US20090185982 Approach to the treatment of compartment syndrome |
| 07/23/2009 | US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof |
| 07/23/2009 | US20090185976 Method for introducing a chemical agent into the systemic circulation |
| 07/23/2009 | DE202006020682U1 Mittel zur Diagnose von rheumatischen Erkrankungen Means for the diagnosis of rheumatic diseases |
| 07/23/2009 | DE19521753B4 Monomere Insulinanalogonformulierungen Monomeric insulin analog formulations |
| 07/23/2009 | DE112007002172T5 A/D-Wandler, A/D-Umwandlungsverfahren, A/D-Umwandlungsprogramm und Steuervorrichtung A / D converter, A / D converting method, A / D conversion program and control device |
| 07/23/2009 | DE102008005097A1 Herstellung und Verwendung antitumoraler Cyclodepsipeptide Production and use of anti-tumor cyclodepsipeptides |
| 07/23/2009 | CA2787097A1 Low viscosity liquid polymeric delivery system |
| 07/23/2009 | CA2713388A1 Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 07/23/2009 | CA2712276A1 Treating neurodegenerative diseases with progranulin (pgrn) |
| 07/23/2009 | CA2712243A1 Instruments and methods for inserting artificial intervertebral implants |
| 07/23/2009 | CA2712057A1 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| 07/23/2009 | CA2711984A1 Powdered protein compositions and methods of making same |
| 07/23/2009 | CA2711972A1 Anti-bacterial compositions |
| 07/23/2009 | CA2711902A1 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart |
| 07/23/2009 | CA2711590A1 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |
| 07/23/2009 | CA2710619A1 Inhibiting angiogenesis using egfl8 antagonists |
| 07/22/2009 | EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness |
| 07/22/2009 | EP2080809A1 Production of modified glycoproteins having multiple antennary structures |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080802A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080766A1 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2080521A1 Gastrin compositions and formulations, and methods of use and preparation |
| 07/22/2009 | EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 07/22/2009 | EP2080519A1 Peptides having binding affinity to an antibody which recognizes an epitope on an alpha1 loop 2 or beta 2 loop 1 of an adrenoreceptor |
| 07/22/2009 | EP2079847A1 Peptides containing tryptophan |
| 07/22/2009 | EP2079835A2 Compositions and methods of using chondroitinase abci mutants |
| 07/22/2009 | EP2079833A1 Compositions and methods for immunotherapy |
| 07/22/2009 | EP2079756A2 Synthetic peptide amides and dimers thereof |
| 07/22/2009 | EP2079526A1 Compositions and uses thereof in the treatment of wounds |
| 07/22/2009 | EP2079479A2 Hcv ns3 protease inhibitors |
| 07/22/2009 | EP2079313A2 Antimicrobial and antiviral compounds and methods for their use |
| 07/22/2009 | EP2006377A9 Novel tumor antigen peptides |
| 07/22/2009 | EP1890718A4 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 07/22/2009 | EP1804825A4 Treatment of neurological deficits in the striatum or substantia nigra pars compacta |
| 07/22/2009 | EP1804822B1 Hcv vaccines for chronic hcv patients |
| 07/22/2009 | EP1802322A4 Prion protein binding materials and methods of use |
| 07/22/2009 | EP1799240A4 Treatment of bone disorders with skeletal anabolic drugs |
| 07/22/2009 | EP1794287B1 Use of il-17- for maturation of oocytes |
| 07/22/2009 | EP1734986A4 Method for modulating appetite |
| 07/22/2009 | EP1664109B1 Purification of glucagon-like peptides |
| 07/22/2009 | EP1623714A4 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases |
| 07/22/2009 | EP1592704B1 Leukocyte stimulating peptides |
| 07/22/2009 | EP1531855A4 Treatment of bone disorders with skeletal anabolic drugs |
| 07/22/2009 | EP1501939B1 Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix |
| 07/22/2009 | EP1453528B1 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 07/22/2009 | EP1443053B1 Analgesic antitumor peptide from scorpion and method of producing it |
| 07/22/2009 | EP1392241B1 System for osmotic delivery of pharmaceutically active agents |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | EP1343518B1 Stabilized interferon compositions |
| 07/22/2009 | EP1292697B1 Method for preparing a physiologically active il-18 polypeptide |
| 07/22/2009 | EP1280900B1 Dendritic cell co-stimulatory molecules |
| 07/22/2009 | EP1244455B1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 07/22/2009 | EP1231840B1 Anti-angiogenic cellular agent for cancer therapy |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | EP1131461B1 Use of hydroxamate compounds for the treatment of HER-2/neu-positive carcinomas |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/22/2009 | EP1093381B2 Antigenic peptides derived from telomerase |
| 07/22/2009 | EP0954326B2 A process for viral inactivation of lyophilized blood proteins |
| 07/22/2009 | EP0873135B1 Peanut allergens and methods |
| 07/22/2009 | CN101489583A Use of non-catalytic form of heparanase and peptides thereof for reversing the anti-coagulant effects of heparinoids |
| 07/22/2009 | CN101489582A Ameliorating agent for brain damage |
| 07/22/2009 | CN101489581A Methods of treating acute blood loss anemia with a cross-linked hemoglobin blood substitute |
| 07/22/2009 | CN101489580A Pharmaceutical composition for treating or preventing hcv infection |
| 07/22/2009 | CN101489579A Prophylactic or therapeutic agent for viral disease |
| 07/22/2009 | CN101489578A Epidermal growth factor increasing insulin secretion and lowering blood glucose |
| 07/22/2009 | CN101489577A Method and compound for the treatment of valvular disease |
| 07/22/2009 | CN101489576A Compositions and methods for modulating vascular development |
| 07/22/2009 | CN101489575A FKBP-L and uses thereof |
| 07/22/2009 | CN101489574A Physiologically active polypeptide- or protein-encapsulatingpolymer micelles, and method for production of the same |
| 07/22/2009 | CN101489573A Methods for treating autoimmune diseases using a TACI-IG fusion molecule |
| 07/22/2009 | CN101489572A Methods for treating and limiting fibrotic disorders and keloids |
| 07/22/2009 | CN101489571A Biosynthetic polypeptide fusion inhibitors |
| 07/22/2009 | CN101486766A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 07/22/2009 | CN101486761A Human coagulation factor VII variants |